Recently, one study described that monounsaturated and polyunsaturated fatty acids could impede the NLRP3 inflammasome activation in metabolic diseases 49, but it was not clear whether CYPs/COX-2 were involved in the activation of NLRP3 inflammasome. The gene discussed is NLRP3; the disease is metabolic disease.